An “unconventional” immune response now identified by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) is a potential new pathway for developing new vaccines for tuberculosis (TB), according to a new publication.
Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health Treatment | Psychedelic Spotlight
New YouGov polling commissioned by clinical trials startup Lindus Health has found that 36% of 18-24 year olds and 30% of 25-49 year olds are